Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Jodi Carter

Associate Professor

University of Alberta

Canada

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Medical Imaging

30%

Radiology

30%

Oncology

30%

Neuroendocrine Tumor

30%

Neuromuscular Disorders

20%

Tuberous Sclerosis

20%

Tumor Microenvironment

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

Multiplex Spatial Proteomic Analysis of HER2–Positive Breast Tumors Reveals Unique Molecular and Immunologic Features Associated With Treatment Response

Article Link

Year:

2025

Changes in breast cancer risk associated with benign breast disease from 1967 to 2013

Article Link

Year:

2025

Microcalcifications in benign breast biopsies: association with lesion type and risk.

Article Link

Year:

2024

Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer.

Article Link

Year:

2024

Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer

Article Link

Year:

2024

Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era

Article Link

Year:

2024

Exuberant circumferential fibroproliferative neuromas in lipomatosis of nerve: a unifying theory. Illustrative case

Article Link

Year:

2024

Neuromuscular choristoma and circumferential nerve territory desmoid-type fibromatosis: imaging findings supporting a nerve-driven mechanism

Article Link

Year:

2024

Neuromuscular choristoma-associated desmoid-type fibromatosis of the brachial plexus: Additional evidence to support a nerve-driven mechanism

Article Link

Year:

2024

Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer

Article Link

Year:

2024

Neuromuscular choristoma and circumferential nerve territory desmoid-type fibromatosis: imaging findings supporting a nerve-driven mechanism.

Article Link

Year:

2023

Noninvasive prediction of axillary lymph node breast cancer metastasis using morphometric analysis of nodal tumor microvessels in a contrast-free ultrasound approach.

Article Link

Year:

2023

Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors.

Article Link

Year:

2023

Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast.

Article Link

Year:

2023

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.

Article Link

Year:

2023

Frequency of HER2 protein overexpression and HER2 gene amplification in endometrial clear cell carcinoma.

Article Link

Year:

2023

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial.

Article Link

Year:

2023

PET imaging characteristics of neuromuscular choristoma and associated desmoid-type fibromatosis.

Article Link

Year:

2023

Unrecognized neuromuscular choristoma with recurrent desmoid-type fibromatosis and Marjolin ulcer: expanding the spectrum of neuromuscular choristoma sequelae within the nerve territory? Illustrative case.

Article Link

Year:

2023

Unrecognized neuromuscular choristoma with recurrent desmoid-type fibromatosis and Marjolin ulcer: expanding the spectrum of neuromuscular choristoma sequelae within the nerve territory? Illustrative case

Article Link

Year:

2023

Collaborators2

Heikki Joensuu

University of Helsinki

FINLAND

Vandana Abramson

Professor of Medicine

UNITED STATES

How do I reach out?

Meet Kite AI